| 2025 | 2024 | 2023 | 2022 | 2021 | 2018 | 2017 | 2015 | 2014 | 2012 | 2011 | 2010 | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | -8,1 k € | -102.8% | 290,0 k € | +2511.6% | -12,0 k € | -50.4% | -8,0 k € | +4.4% | -8,4 k € | +11.0% | -9,4 k € | -163.6% | 14,8 k € | +101.1% | -1,4 M € | -13.0% | -1,2 M € | +80.0% | -6,1 M € | -145.6% | -2,5 M € | -121.1% | -1,1 M € | |
| EBITDA | -8,6 k € | -103.0% | 289,5 k € | +2421.6% | -12,5 k € | -48.4% | -8,4 k € | +4.2% | -8,8 k € | +24.5% | -11,6 k € | -171.6% | 16,2 k € | +100.7% | -2,3 M € | -26.3% | -1,8 M € | +72.7% | -6,7 M € | -133.9% | -2,9 M € | -136.8% | -1,2 M € | |
| Operating profit | -8,6 k € | -103.0% | 289,5 k € | +2421.6% | -12,5 k € | -48.4% | -8,4 k € | +4.2% | -8,8 k € | +24.5% | -11,6 k € | -181.9% | 14,2 k € | +100.6% | -2,4 M € | -23.9% | -1,9 M € | +71.6% | -6,8 M € | -131.0% | -2,9 M € | -128.9% | -1,3 M € | |
| Profit/loss | -6,0 k € | -102.1% | 290,8 k € | +2565.4% | -11,8 k € | -38.3% | -8,5 k € | +4.4% | -8,9 k € | +26.1% | -12,1 k € | -185.9% | 14,1 k € | +100.6% | -2,5 M € | -20.2% | -2,1 M € | +68.7% | -6,8 M € | -129.4% | -3,0 M € | -129.0% | -1,3 M € | |
| Equity | 421,1 k € | -1.4% | 427,1 k € | +80.8% | 236,2 k € | -4.8% | 248,0 k € | -3.3% | 256,6 k € | -11.4% | 289,4 k € | -4.0% | 301,5 k € | +185.3% | -353,3 k € | +79.2% | -1,7 M € | -132.8% | 5,2 M € | -15.3% | 6,1 M € | +748.0% | 719,1 k € | |
| Total assets | 421,1 k € | -20.1% | 527,1 k € | +121.6% | 237,9 k € | -4.1% | 248,0 k € | -3.3% | 256,6 k € | -11.4% | 289,6 k € | -6.7% | 310,5 k € | -56.2% | 708,7 k € | -45.4% | 1,3 M € | -78.1% | 5,9 M € | -11.8% | 6,7 M € | +652.7% | 892,0 k € | |
| Cash | 416,3 k € | -20.4% | 523,2 k € | +123.1% | 234,5 k € | -4.5% | 245,7 k € | -3.3% | 254,2 k € | -11.4% | 286,9 k € | -6.6% | 307,0 k € | +54.8% | 198,3 k € | -60.0% | 495,8 k € | -90.6% | 5,3 M € | -14.4% | 6,2 M € | +1184.7% | 481,3 k € | |
| Debts | 0,0 € | -100.0% | 100,0 k € | +6055.6% | 1,6 k € | — | 0,0 € | -100.0% | 129,8 € | -98.6% | 9,0 k € | -99.1% | 1,0 M € | -61.4% | 2,7 M € | +279.0% | 702,1 k € | +19.4% | 588,2 k € | +240.0% | 173,0 k € | |||
| Staff | — | — | — | — | — | — | — | 9,5 | 8,3 | 8 | 5 | 3 | ||||||||||||
Public limited company · Hasselt · incorporated on 23/07/2009
Public limited company loss-making in the latest fiscal year. Cash position declining (-20.4%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
| Unit no. | Name | Location |
|---|---|---|
| 2180461812 | AMAKEM | Kuringersteenweg 172, 3500 Hasselt |
AMAKEM is a Public limited company incorporated in 2009. Its main activity is: Activités des laboratoires médicaux. Its registered office is in Hasselt.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette